DSGN
Price
$10.37
Change
+$3.25 (+45.65%)
Updated
Feb 3 closing price
Capitalization
590.14M
41 days until earnings call
Intraday BUY SELL Signals
SLDB
Price
$6.54
Change
+$0.14 (+2.19%)
Updated
Feb 3 closing price
Capitalization
500.96M
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs SLDB

Header iconDSGN vs SLDB Comparison
Open Charts DSGN vs SLDBBanner chart's image
Design Therapeutics
Price$10.37
Change+$3.25 (+45.65%)
Volume$148.79K
Capitalization590.14M
Solid Biosciences
Price$6.54
Change+$0.14 (+2.19%)
Volume$1.03M
Capitalization500.96M
DSGN vs SLDB Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
SLDB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. SLDB commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and SLDB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (DSGN: $10.37 vs. SLDB: $6.54)
Brand notoriety: DSGN and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 37% vs. SLDB: 104%
Market capitalization -- DSGN: $590.14M vs. SLDB: $510.7M
DSGN [@Biotechnology] is valued at $590.14M. SLDB’s [@Biotechnology] market capitalization is $510.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 5 bullish TA indicator(s).

  • DSGN’s TA Score: 4 bullish, 3 bearish.
  • SLDB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both DSGN and SLDB are a good buy in the short-term.

Price Growth

DSGN (@Biotechnology) experienced а -2.08% price change this week, while SLDB (@Biotechnology) price change was -0.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($590M) has a higher market cap than SLDB($501M). SLDB YTD gains are higher at: 14.007 vs. DSGN (10.554). DSGN has higher annual earnings (EBITDA): -77.38M vs. SLDB (-170.67M). SLDB has more cash in the bank: 236M vs. DSGN (206M). DSGN has less debt than SLDB: DSGN (1.74M) vs SLDB (21.9M). DSGN (0) and SLDB (0) have equivalent revenues.
DSGNSLDBDSGN / SLDB
Capitalization590M501M118%
EBITDA-77.38M-170.67M45%
Gain YTD10.55414.00775%
P/E RatioN/AN/A-
Revenue00-
Total Cash206M236M87%
Total Debt1.74M21.9M8%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNSLDB
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
89%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
SLDB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COVUX14.790.17
+1.16%
Columbia Overseas Value R
VRSCX28.060.03
+0.11%
Voya SmallCap Opportunities Port R6
BALSX9.67N/A
N/A
BlackRock U.S. Insights Lon/Shr Eq Inv A
BIASX19.87-0.15
-0.75%
Brown Advisory Small-Cap Growth Inv
GRISX31.08-0.27
-0.86%
Nationwide S&P 500 Index Instl Svc

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-0.38%
IDYA - DSGN
51%
Loosely correlated
+0.50%
DYN - DSGN
51%
Loosely correlated
+1.07%
SLDB - DSGN
50%
Loosely correlated
+1.71%
SYRE - DSGN
49%
Loosely correlated
+1.65%
VRDN - DSGN
49%
Loosely correlated
-3.92%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-0.46%
EDIT - SLDB
52%
Loosely correlated
+1.01%
DSGN - SLDB
50%
Loosely correlated
+1.96%
BCYC - SLDB
47%
Loosely correlated
+1.09%
CRBU - SLDB
46%
Loosely correlated
+3.55%
AURA - SLDB
46%
Loosely correlated
+5.00%
More